The talk at the 2004 RSNA meeting was all about CT. Even with only the smallest handful of papers presented on 64-slice experience, radiologists discussed the latest generation of scanner as the new must-have equipment.
The talk at the 2004 RSNA meeting was all about CT. Even with only the smallest handful of papers presented on 64-slice experience, radiologists discussed the latest generation of scanner as the new must-have equipment.
While still largely unproven, the potential is great, and the focus is on cardiovascular applications. The ability to characterize and quantify both calcified and soft plaques is hailed as a step up from older calcium scoring studies, even if the exact course of treatment for a given plaque burden is still uncertain. Studies of the heart's vessels are competitive with traditional angiography and ultrasound, though the need for further research remains.
In this supplement, Diagnostic Imaging looks at how CT technology is shaping cardiovascular imaging and practice: innovators who have been successful at obtaining reimbursement for studies, researchers who are testing the limits of plaque analysis, and teams of cardiologists and radiologists who are working together to ensure that each contributes expertise to cardiac evaluation and treatment built on these evolving techniques.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.